Jackson Square Capital’s Bristol-Myers Squibb BMY Stock Holding History

Jackson Square Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$547K	Sell	9,490 -51,820	-85%	-$2.98M	0.08%	100
2026 Q1	$3.72M	Buy	+61,310	New	+$3.57M	0.78%	32
2025 Q2	–	Sell	-24,953	Closed	-$1.52M	–	149
2025 Q1	$1.52M	Buy	24,953 +747	+3%	+$43.5K	0.49%	45
2024 Q4	$1.37M	Buy	+24,206	New	+$1.35M	0.33%	57
2022 Q3	–	Sell	-7,952	Closed	-$612K	–	126
2022 Q2	$612K	Hold	7,952	–	–	0.26%	76
2022 Q1	$581K	Buy	7,952 +3,526	+80%	+$237K	0.18%	101
2021 Q4	$276K	Sell	4,426 -39,689	-90%	-$2.33M	0.08%	170
2021 Q3	$2.61M	Sell	44,115 -631	-1%	-$41.6K	0.85%	38
2021 Q2	$2.99M	Sell	44,746 -108	-0.2%	-$7.04K	0.96%	36
2021 Q1	$2.83M	Sell	44,854 -2,358	-5%	-$147K	1.08%	31
2020 Q4	$2.93M	Sell	47,212 -845	-2%	-$52K	1.13%	33
2020 Q3	$2.9M	Sell	48,057 -785	-2%	-$47.2K	1.28%	33
2020 Q2	$2.87M	Buy	48,842 +10,683	+28%	+$639K	1.45%	26
2020 Q1	$2.13M	Buy	38,159 +35,316	+1,242%	+$2.16M	1.65%	20
2019 Q4	$182K	Buy	+2,843	New	+$163K	0.11%	100

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jackson Square Capital's BMY Position: Q2 2026 in Review

Jackson Square Capital reduced its Bristol-Myers Squibb (BMY) stake by 85% in Q2 2026, selling an estimated $2.98M and leaving 9,490 shares worth $547K. The position accounts for 0.08% of the portfolio, ranked #100.

Jackson Square Capital first reported a position in BMY in Q4 2019 and has held it in 15 quarters since. The position peaked at $3.72M in Q1 2026. 2,516 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Jackson Square Capital held 9,490 shares of Bristol-Myers Squibb worth $547K as of Q2 2026.
Jackson Square Capital sold 51,820 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.98M.
Bristol-Myers Squibb made up 0.08% of Jackson Square Capital's portfolio in Q2 2026, its #100 holding.
Jackson Square Capital first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 15 quarters since.
Jackson Square Capital's Bristol-Myers Squibb position peaked at $3.72M in Q1 2026.
2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.